Home Top Movers What’s Making Lineage Cell Therapeutics (LCTX) Tick?

What’s Making Lineage Cell Therapeutics (LCTX) Tick?

In early trading on Wednesday, shares of a clinical-stage biotechnology company, Lineage Cell Therapeutics Inc (LCTX) jumped as much as 10.10% to $2.73, a price which is above its previous 52-week high of $2.58.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

So What’s Keeping The Stock Alive?

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Lineage Cell was kept quiet today, so what’s keeping the stock alive? Perhaps the company didn’t release any press releases or financial information, and that might be the good news.

Read More

However, Age-related Macular Degeneration (AMD) with spatial atrophy of Lineage Cell Therapeutics is being in process in a phase 1/2a clinical trial using OpRegen, which has shown preliminary efficacy and tolerability. The ongoing OpRegen analysis is expected to show fresh data this quarter. Another phase I clinical trial of VAC2 for the treatment of non-small cell lung cancer is also scheduled to be concluded by the end of 2021.

Lineage Cell Therapeutics came out in favor of Proposition 14, which passed recently in California. By authorizing the California Institute for Regenerative Medicine (CIRM) to fund up to $5.5 billion in grants to support therapeutic development, medical research, and facilities based on stem cell technologies, this bill will improve patients’ access to groundbreaking stem cell therapy treatments.

In the third quarter of 2020, LCTX was part of the portfolios of 8 hedge funds. Its high for this figure was 13. Lineage Cell Therapeutics’ earnings per share fell shy of expectations in Q3, coming in at -$0.05, against analysts’ expectations of -$0.04.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Analysts’ Viewpoint

Alternatively, Lineage Cell Therapeutics Inc (LCTX) is well-received by Dawson James, as the analyst firm set a price target of $6.00 on October 12, 2020, and has given LCTX a Buy rating.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Why AbCellera Biologics Inc. (ABCL) stock faced negativity on Tuesday?

AbCellera Biologics Inc. (ABCL) shares lost 2.13% in after-hours on Tuesday, June 22, 2021, and closed the day at $21.60 per share. Earlier, ABCL's...

Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?

Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with...

Comstock Mining Inc. (LODE) stock soar during pre-market trading. What’s happening?

Comstock Mining Inc. (NASDAQ: LODE) stock gained by 1.14% at last close while the LODE stock price surged by 3.10% in the pre-market trading...

Why MediciNova Inc (MNOV) stock facing negativity since Monday’s after-hours?

MediciNova Inc. (MNOV) shares lost 5.71% in after-hours on Monday, June 21, 2021, and the plummeting continues in the pre-market session on Tuesday as...

Adial Pharmaceuticals Inc. (ADIL) stock plunged during pre-market trading. Here’s to know why?

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) stock gained by 9.06% at last close while the ADIL share price fell by 6.07% in the pre-market trading...

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Pyxis Tankers Inc. (PXS) stock fell during pre-market trading. Why so?

Pyxis Tankers Inc. (NASDAQ: PXS) stock declined by 0.06% at the last close while the PXS stock price plunged by 6.15% in the pre-market...

Related News

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen...

Why STAAR Surgical Company (STAA) stock went up on Tuesday?

STAAR Surgical Company (STAA) shares rose 5.84% in after-hours on Tuesday, June 22, 2021, and closed the day at $151.25 per share. earlier in...

Is Colony Capital Inc (CLNY) stock transformation resulted in a minor loss on Tuesday?

Colony Capital Inc. (CLNY) shares lost 0.94% on Tuesday, June 22, 2021, and closed at $8.42 per share. In the after-hours session, the CLNY...

Tupperware Brands Corp. (TUP) stock soar during pre-market trading. Here’s to know why?

Tupperware Brands Corp. (NASDAQ: TUP) stock gained by 0.3% at the last close while the TUP stock price surged by 6.83% in the pre-market...

Why Eyenovia Inc. (EYEN) stock price went up in the after-market on Friday?

Eyenovia Inc. (EYEN) shares pop up 8.41% in after-hours on Friday, June 18, 2021, and close the week at $5.80 per share. Earlier, EYEN's...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

7542

GIFT

Download free eBook for 

7 GROWTH  STOCKS FOR 2021

WAIT 
WE HAVE GIFT FOR YOU

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam